Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lass, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lass, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 6, 1055-1057, June 2001
© 2001 European Society of Human Reproduction and Embryology

Assessment of ovarian reserve – is there a role for ovarian biopsy?

Amir Lass,1

Bourn Hall Clinic, Bourn, Cambridge CB3 7TR, UK

The pool of primordial follicles in the ovary or `ovarian reserve' is a major factor in the human fertility potential. The ageing ovary is characterized by reduction of the number of primordial follicles and this loss accelerates in the late 30's and precedes the menopause by 10–12 years. Woman's age alone or with a combination of biochemical markers, dynamic tests and ultrasound measurements fail to predict this loss accurately. In this manuscript, a novel approach of histopathological examination of ovarian biopsy for the evaluation of infertility, especially in unexplained infertility and in women in the later part of reproductive life, is discussed.

Key words: follicles/ovarian biopsy/ovarian reserve

1 To whom correspondence should be addressed at: Serono Pharmaceuticals, Bedfont Cross, Stanwell Road, Feltham, Middlesex TW14 8NX, UK. E-mail: amir.lass{at}serono.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk
A systematic review of tests predicting ovarian reserve and IVF outcome
Hum. Reprod. Update, November 1, 2006; 12(6): 685 - 718.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.H. Woldringh, M.H.A. Frunt, J.A.M. Kremer, and M.E.A. Spaanderman
Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies
Hum. Reprod., November 1, 2006; 21(11): 2948 - 2954.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. K. Skinner
Regulation of primordial follicle assembly and development
Hum. Reprod. Update, September 1, 2005; 11(5): 461 - 471.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
Hum. Reprod., April 1, 2005; 20(4): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, F. Carmona, R. Casamitjana, J. A. Vanrell, and J. Balasch
Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment
Hum. Reprod., March 1, 2005; 20(3): 622 - 628.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, P. C. Smith, and A. E. Taylor
Evidence of Early Ovarian Aging in Fragile X Premutation Carriers
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4569 - 4574.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Lass
Assessment of ovarian reserve: Is there still a role for ovarian biopsy in the light of new data?
Hum. Reprod., March 1, 2004; 19(3): 467 - 469.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. I. Sharara and R. T. Scott
Assessment of ovarian reserve. Is there still a role for ovarian biopsy?: First do no harm!
Hum. Reprod., March 1, 2004; 19(3): 470 - 471.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. C. Larsen, J. Muller, K. Schmiegelow, C. Rechnitzer, and A. N. Andersen
Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5307 - 5314.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.